NEW YORK (GenomeWeb News) – 23andMe today announced it has acquired CureTogether for an undisclosed amount.
Based in Mountain View, Calif., CureTogether is a community-based health site where members can share quantitative information about more than 500 medical conditions. The purchase is the first by 23andMe, which said that it provides the firm with "technology and talent that will improve 23andMe's ability to gather data for research, while also providing customers with engaging and meaningful interactions in 23andMe's online community."
Launched in 2008, CureTogether has more than 4 million phenotypic data points across more than 500 medical conditions that may prove useful in genetic discoveries, 23andMe said, adding that the tools and systems that CureTogether brings will allow customers to discuss their symptoms and compare which treatments may work best for them.
Daniel Reda and Alexandra Carmichael, co-founders of CureTogether, are joining 23andMe as senior product managers.
23andMe CEO and Co-Founder Anne Wojcicki said in a statement that the deal "underscores 23andMe's commitment to helping individuals understand their own genetic information through proven DNA analysis technologies and web-based interactive tools; and generating patient-driven, informed-consent research as well as empowering our customers to use their personal genetic information to find connections and establish communities based on their DNA."